Disc Medicine, Inc.

IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001816736

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Apr 13, 2022Apr 12, 2022Leonard Braden Michael10% OwnerPPurchaseCommon Stock+55K$1.37+$75.35K270K+25.6%SEC
Apr 13, 2022Apr 11 – Apr 13, 2022Leonard Braden Michael10% OwnerPPurchaseCommon Stock+900K$1.4021+$1.26M5M+22.0%SEC
Oct 27, 2022Oct 26, 2022Leonard Braden Michael10% OwnerSSaleCommon Stock−22.5K$2.09−$47.03K247.5K−8.3%SEC
Feb 17, 2023Feb 15, 2023Ashiya MonaDirector, 10% OwnerPPurchaseCommon Stock+108.7K$23.00+$2.5M299.21K+57.1%SEC
Feb 17, 20234:42 PM ETFeb 15, 2023Blavatnik Len and 3 others10% OwnerPPurchaseCommon Stock+434.78K$23.00+$10M3.14M+16.1%SEC
Feb 17, 20234:43 PM ETFeb 15, 2023ORBIMED ADVISORS LLC and 3 othersDirector, 10% OwnerPPurchaseCommon Stock+108.7K$23.00+$2.5M299.21K+57.1%SEC
Jun 20, 20234:01 PM ETJun 16, 2023Blavatnik Len and 3 others10% OwnerPPurchaseCommon Stock · Derivative+204.08K$48.9999+$10M204.08K–SEC
Jun 28, 2023Jun 28, 2023Novo Holdings A/S10% OwnerSSaleCommon Stock−1.25M$46.10−$57.63M1.09M−53.4%SEC
Jun 30, 2023Jun 28, 2023Savage William JacobChief Medical OfficerSSaleCommon Stock−4.38K$49.9795−$219.11K15.94K−21.6%SEC10b5-1
Jun 30, 2023Jun 28, 2023Bryce JoanneChief Financial OfficerSSaleCommon Stock−10.07K$49.9532−$503.13K1.26K−88.9%SEC10b5-1
Jun 30, 2023Jun 28 – Jun 30, 2023MacDonald Brian RichardChief Innovation OfficerSSaleCommon Stock−14.52K$47.0288−$683.05K12.88K−53.0%SEC10b5-1
Jun 30, 2023Jun 30, 2023MacDonald Brian RichardChief Innovation OfficerSSaleCommon Stock+600$46.76+$28.06K12.28K+5.1%SEC10b5-1
Aug 3, 2023Aug 1, 2023Bryce JoanneChief Financial OfficerSSaleCommon Stock−4.52K$49.9098−$225.64K1.26K−78.2%SEC10b5-1
Aug 11, 2023Aug 9, 2023Savage William JacobChief Medical OfficerSSaleCommon Stock−8.27K$49.8328−$412.07K7.67K−51.9%SEC10b5-1
Aug 16, 2023Aug 15, 2023Savage William JacobChief Medical OfficerSSaleCommon Stock−7.67K$52.9493−$406.23K0−100.0%SEC10b5-1
Aug 16, 20236:55 PM ETAug 14 – Aug 15, 2023Atlas Venture Fund X, L.P. and 5 others10% OwnerSSaleCommon Stock−286.07K$52.5175−$15.02M1.95M−12.8%SEC
Aug 16, 20236:55 PM ETAug 15, 2023Atlas Venture Fund X, L.P. and 5 others10% OwnerSSaleCommon Stock−72.93K$52.40−$3.82M882.22K−7.6%SEC
Aug 17, 2023Aug 15, 2023Bitterman KevinDirectorSSaleCommon Stock−72.93K$52.40−$3.82M882.22K−7.6%SEC
Sep 5, 2023Sep 1, 2023Bryce JoanneChief Financial OfficerSSaleCommon Stock−1K$52.99−$52.99K1.26K−44.2%SEC10b5-1
Sep 18, 20234:59 PM ETSep 14 – Sep 16, 2023Atlas Venture Fund X, L.P. and 2 others10% OwnerSSaleCommon Stock−357.45K$53.1313−$18.99M1.59M−18.3%SEC
Nov 7, 2023Nov 3, 2023Khara RahulGeneral CounselSSaleCommon Stock−100$50.00−$5K0−100.0%SEC10b5-1
Nov 15, 2023Nov 14, 2023Khara RahulGeneral CounselSSaleCommon Stock−4.9K$50.6135−$248.01K0−100.0%SEC10b5-1
Nov 27, 2023Nov 22, 2023Khara RahulGeneral CounselSSaleCommon Stock−10K$51.7359−$517.36K0−100.0%SEC10b5-1
Dec 7, 2023Dec 5, 2023Bryce JoanneChief Financial OfficerSSaleCommon Stock−2.54K$56.0008−$142.3K2.5K−50.4%SEC10b5-1
Dec 14, 2023Dec 12 – Dec 14, 2023Ashiya MonaDirectorSSaleCommon Stock−134.2K$58.8842−$7.9M727.81K−15.6%SEC
Dec 14, 2023Dec 12, 2023Bryce JoanneChief Financial OfficerSSaleCommon Stock−2.5K$65.22−$163.05K2.5K−50.0%SEC10b5-1
Dec 14, 2023Dec 12, 2023White William RichardDirectorSSaleCommon Stock−33.51K$63.2104−$2.12M0−100.0%SEC
Dec 14, 2023Dec 12 – Dec 14, 2023Bitterman KevinDirectorSSaleCommon Stock−76.06K$61.4451−$4.67M806.16K−8.6%SEC
Dec 14, 20235:44 PM ETDec 12 – Dec 14, 2023ORBIMED ADVISORS LLC and 3 othersDirectorSSaleCommon Stock−134.2K$58.8842−$7.9M727.81K−15.6%SEC
Dec 14, 20238:13 PM ETDec 12 – Dec 14, 2023Atlas Venture Fund X, L.P. and 5 others10% OwnerSSaleCommon Stock−114.1K$61.4451−$7.01M1.48M−7.2%SEC
Dec 14, 20238:13 PM ETDec 12 – Dec 14, 2023Atlas Venture Fund X, L.P. and 5 others10% OwnerSSaleCommon Stock−76.06K$61.4451−$4.67M806.16K−8.6%SEC
Dec 15, 2023Dec 14, 2023Ashiya MonaDirectorSSaleCommon Stock−433.2K$56.75−$24.58M224.41K−65.9%SEC
Dec 15, 20236:04 PM ETDec 14, 2023ORBIMED ADVISORS LLC and 3 othersDirectorSSaleCommon Stock−433.2K$56.75−$24.58M224.41K−65.9%SEC
Dec 20, 2023Dec 18, 2023Ashiya MonaDirectorSSaleCommon Stock−1.72K$59.24−$102.13K0−100.0%SEC
Dec 20, 20236:28 PM ETDec 18, 2023ORBIMED ADVISORS LLC and 3 othersDirectorSSaleCommon Stock−1.72K$59.24−$102.13K0−100.0%SEC
Jan 12, 2024Jan 10, 2024Bitterman KevinDirectorSSaleCommon Stock−20K$64.00−$1.28M786.16K−2.5%SEC
Jan 12, 20245:12 PM ETJan 10, 2024Atlas Venture Fund X, L.P. and 5 others10% OwnerSSaleCommon Stock−30K$64.00−$1.92M1.45M−2.0%SEC
Jan 12, 20245:12 PM ETJan 10, 2024Atlas Venture Fund X, L.P. and 5 others10% OwnerSSaleCommon Stock−20K$64.00−$1.28M786.16K−2.5%SEC
Jan 25, 2024Jan 23, 2024Bitterman KevinDirectorSSaleCommon Stock−102.5K$67.65−$6.93M198.33K−34.1%SEC
Jan 25, 20244:31 PM ETJan 23, 2024Atlas Venture Fund X, L.P. and 8 others10% OwnerSSaleCommon Stock−47.5K$67.65−$3.21M1.4M−3.3%SEC
Jan 25, 20244:31 PM ETJan 23, 2024Atlas Venture Fund X, L.P. and 8 others10% OwnerSSaleCommon Stock−102.5K$67.65−$6.93M198.33K−34.1%SEC
Mar 7, 2024Mar 5, 2024Bitterman KevinDirectorSSaleCommon Stock−26.16K$73.50−$1.92M677.5K−3.7%SEC
Apr 15, 2024Apr 11, 2024White William RichardDirectorSSaleCommon Stock−2.56K$31.8019−$81.41K0−100.0%SEC10b5-1
May 3, 2024May 1, 2024White William RichardDirectorSSaleCommon Stock−201$28.6345−$5.76K0−100.0%SEC10b5-1
Jun 5, 2024Jun 3, 2024White William RichardDirectorSSaleCommon Stock−1.96K$36.0782−$70.6K0−100.0%SEC10b5-1
Jun 20, 2024Jun 17, 2024Ashiya MonaDirectorPPurchaseCommon Stock+83.33K$36.00+$3M235.39K+54.8%SEC
Jun 20, 2024Jun 17, 2024Bitterman KevinDirectorPPurchaseCommon Stock+222.22K$36.00+$8M420.55K+112.0%SEC
Jun 20, 20245:19 PM ETJun 17, 2024ORBIMED ADVISORS LLC and 3 othersDirectorPPurchaseCommon Stock+83.33K$36.00+$3M235.39K+54.8%SEC
Jul 3, 2024Jul 1, 2024White William RichardDirectorSSaleCommon Stock−201$46.039−$9.25K0−100.0%SEC10b5-1
Aug 5, 2024Aug 1, 2024White William RichardDirectorSSaleCommon Stock−201$43.4413−$8.73K0−100.0%SEC10b5-1